78 related articles for article (PubMed ID: 17369393)
1. Long-term prospective pilot study with tranilast for the prevention of stricture progression in patients with Crohn's disease.
Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
Gut; 2007 Apr; 56(4):599-600. PubMed ID: 17369393
[No Abstract] [Full Text] [Related]
2. Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab.
Bouguen G; Trouilloud I; Siproudhis L; Oussalah A; Bigard MA; Bretagne JF; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2009 Oct; 30(7):749-56. PubMed ID: 19583709
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
Lichtenstein GR; Olson A; Travers S; Diamond RH; Chen DM; Pritchard ML; Feagan BG; Cohen RD; Salzberg BA; Hanauer SB; Sandborn WJ
Am J Gastroenterol; 2006 May; 101(5):1030-8. PubMed ID: 16606351
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies.
Plamondon S; Ng SC; Kamm MA
Aliment Pharmacol Ther; 2007 Mar; 25(5):557-67. PubMed ID: 17305756
[TBL] [Abstract][Full Text] [Related]
5. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
6. A pilot study comparing hydrocortisone premedication to concomitant azathioprine treatment in preventing loss of response to infliximab.
Mantzaris GJ; Viazis N; Petraki K; Papamichael K; Theodoropoulos I; Roussos A; Karakoidas C; Koilakou S; Raptis N; Smyrnidis A; Agalos G; Karamanolis DG
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1042-8. PubMed ID: 20139856
[TBL] [Abstract][Full Text] [Related]
7. Can postoperative relapse of Crohn's disease be prevented?
Dumois RA; Herrera JL
Am J Gastroenterol; 2001 Jan; 96(1):249. PubMed ID: 11197264
[No Abstract] [Full Text] [Related]
8. Uncontrollable prurigo nodularis effectively treated by roxithromycin and tranilast.
Horiuchi Y; Bae S; Katayama I
J Drugs Dermatol; 2006 Apr; 5(4):363-5. PubMed ID: 16673805
[TBL] [Abstract][Full Text] [Related]
9. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J
Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
[TBL] [Abstract][Full Text] [Related]
10. Cheilitis granulomatosa and Melkersson-Rosenthal syndrome: evaluation of gastrointestinal involvement and therapeutic regimens in a series of 14 patients.
Ratzinger G; Sepp N; Vogetseder W; Tilg H
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1065-70. PubMed ID: 17714126
[TBL] [Abstract][Full Text] [Related]
11. Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
Biancone L; Tosti C; Geremia A; Fina D; Petruzziello C; Emerenziani S; Pallone F
Aliment Pharmacol Ther; 2004 Apr; 19(7):755-64. PubMed ID: 15043516
[TBL] [Abstract][Full Text] [Related]
12. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
Basturk T; Ozagari A; Ozturk T; Kusaslan R; Unsal A
J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697
[TBL] [Abstract][Full Text] [Related]
13. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Feagan BG
Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
[No Abstract] [Full Text] [Related]
14. Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions.
Delgado J; Delgado B; Sztarkier I; Cagnano E; Sperber AD; Fich A
Isr Med Assoc J; 2003 Dec; 5(12):897-8. PubMed ID: 14689766
[No Abstract] [Full Text] [Related]
15. Possible antistenotic effect of tranilast in a patient with small bowel tuberculosis to prevent intestinal obstruction due to stenosis progression by antituberculous chemotherapy.
Oshitani N; Takeda S; Matsumoto H; Minamino H; Hayakawa T; Aomatsu K
Dig Endosc; 2013 May; 25(3):333-5. PubMed ID: 23363021
[TBL] [Abstract][Full Text] [Related]
16. Colonoscopic balloon dilation of Crohn's strictures: a review of long-term outcomes.
Thomas-Gibson S; Brooker JC; Hayward CM; Shah SG; Williams CB; Saunders BP
Eur J Gastroenterol Hepatol; 2003 May; 15(5):485-8. PubMed ID: 12702904
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
Egan LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
[TBL] [Abstract][Full Text] [Related]
19. Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.
Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E;
Am J Gastroenterol; 2002 Mar; 97(3):649-53. PubMed ID: 11922560
[TBL] [Abstract][Full Text] [Related]
20. [An unexplained inflammatory syndrome could be due to renal amyloidosis associated to Crohn's disease].
Fekih M; Hefaiedh R; Matri S; Djebbi S; Boubaker J; Filali A
Tunis Med; 2008 Nov; 86(11):1022-3. PubMed ID: 19213504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
